Gates Foundation is funding EU Biotech to make Vaccines more affordable

10/06/2016 - 3 minutes

Batavia Biosciences has won a €3.3M grant from the Gates Foundation, to fund new research in making cell culture cheaper – and drive down the price of some key vaccines.

batavia_cell_vaccines_manufacturing_gatesWithin its goal of pushing science forward and bringing to developing countries, the Gates Foundation has outlined vaccine delivery as a key part of its strategy.

The foundation has invested in communications to emphasize the importance of vaccines (such as the work of Zim & Zou), but is also tackling a more technical challenge – the price of vaccines.

Vaccines are often expensive for the world’s poorest countries. Along with supply shortages and a lack of trained health workers, this leads to a sad fact –  an estimated 1.5 million children die each year from vaccine-preventable diseases.

Now, Bill&Melinda Foundation has awarded Batavia Biosciences a €3.3M ($3.8M) grant. Based in Leiden (Netherlands), Batavia will use it expertise in manufacturing to cut costs in the process through which cells produce specific virus –

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member